Mark B. Lockwood

1.8k total citations · 2 hit papers
33 papers, 1.3k citations indexed

About

Mark B. Lockwood is a scholar working on Nephrology, Oncology and Epidemiology. According to data from OpenAlex, Mark B. Lockwood has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 8 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Mark B. Lockwood's work include Dialysis and Renal Disease Management (9 papers), Gut microbiota and health (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Mark B. Lockwood is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Gut microbiota and health (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Mark B. Lockwood collaborates with scholars based in United States, India and United Kingdom. Mark B. Lockwood's co-authors include Gregory A. Storch, Mark A. Schnitzler, Daniel C. Brennan, Karen L. Hardinger, Monique Gaudreault‐Keener, Daniel L. Bohl, Irfan Agha, Delphine Bohl, Matthew J. Koch and Jad A. Khoury and has published in prestigious journals such as Journal of Medicinal Chemistry, Transplantation and American Journal of Transplantation.

In The Last Decade

Mark B. Lockwood

30 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction

2005 540 citations Daniel C. Brennan, Irfan Agha et al. American Journal of Transplantation profile →
Patient-centred approaches for the management of unpleasant symptoms in kidney disease

2022 113 citations Kamyar Kalantar‐Zadeh, Mark B. Lockwood et al. Nature Reviews Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark B. Lockwood United States	13	670	328	285	259	156	33	1.3k
Maher A. Baz United States	26	216 0.3×	422 1.3×	450 1.6×	273 1.1×	32 0.2×	61	1.7k
Robert Leduc United States	21	119 0.2×	178 0.5×	1.2k 4.1×	184 0.7×	210 1.3×	36	1.6k
Kylie‐Ann Mallitt Australia	21	350 0.5×	282 0.9×	7 0.0×	120 0.5×	39 0.3×	67	1.4k
Olympia E. Anastasiou Germany	19	113 0.2×	315 1.0×	22 0.1×	655 2.5×	4 0.0×	69	1.3k
Merja Möttönen Finland	20	335 0.5×	230 0.7×	3 0.0×	106 0.4×	27 0.2×	38	1.1k
Julio Collazos Spain	21	93 0.1×	423 1.3×	7 0.0×	727 2.8×	127 0.8×	79	1.5k
Michael O. Rigsby United States	17	677 1.0×	865 2.6×	16 0.1×	559 2.2×	72 0.5×	21	1.4k
Jean‐Michel Hougardy Belgium	17	39 0.1×	278 0.8×	117 0.4×	372 1.4×	35 0.2×	34	827
Nicholas I. Paton United Kingdom	18	93 0.1×	493 1.5×	5 0.0×	1.4k 5.5×	30 0.2×	39	2.7k
Dale Gardiner United Kingdom	18	60 0.1×	52 0.2×	95 0.3×	168 0.6×	16 0.1×	77	1.1k

Countries citing papers authored by Mark B. Lockwood

Since Specialization

Citations

This map shows the geographic impact of Mark B. Lockwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Lockwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Lockwood more than expected).

Fields of papers citing papers by Mark B. Lockwood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Lockwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Lockwood. The network helps show where Mark B. Lockwood may publish in the future.

Co-authorship network of co-authors of Mark B. Lockwood

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Lockwood. A scholar is included among the top collaborators of Mark B. Lockwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Lockwood. Mark B. Lockwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Charytan, David M., Alvin H. Moss, Wenbo Wu, et al.. (2025). Fall Risk in Maintenance Hemodialysis Patients. Clinical Journal of the American Society of Nephrology. 20(9). 1247–1258.

Mathew, Asha, et al.. (2023). Symptom Cluster Experiences of Patients Operated for Oral Cancer: A Mixed Methods Study. Seminars in Oncology Nursing. 39(3). 151407–151407. 4 indexed citations

Lockwood, Mark B., et al.. (2023). Effects of Spaceflight on the Human Gastrointestinal Tract Microbiome. Journal of the Indian Institute of Science. 103(3). 761–769. 1 indexed citations

Lockwood, Mark B., et al.. (2023). Sleep Disturbances in Older Adults Receiving Dialysis. Nephrology Nursing Journal. 50(6). 467–467.

Jang, Min Kyeong, et al.. (2022). Health Belief Model Constructs Affect Influenza Vaccine Uptake in Kidney Transplant Recipients. Western Journal of Nursing Research. 45(5). 395–401. 1 indexed citations

Lockwood, Mark B., George E. Chlipala, Holli A. DeVon, et al.. (2022). Pain Interference in End Stage Kidney Disease is Associated with Changes in Gut Microbiome Features Before and After Kidney Transplantation. Pain Management Nursing. 24(1). 68–77. 2 indexed citations

Li, Hongjin, Mark B. Lockwood, Judith M. Schlaeger, et al.. (2022). Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors. Pain Management Nursing. 24(1). 52–59. 9 indexed citations

Lockwood, Mark B., Michael J. Fischer, Amanda Goldstein, et al.. (2022). Acceptability and feasibility of fecal microBIOME and serum metabolite sample collection in people with end-stage kidney disease and pain being treated with HemoDialysis: A pilot study (BIOME-HDp). Contemporary Clinical Trials Communications. 29. 100995–100995.

Kalantar‐Zadeh, Kamyar, Mark B. Lockwood, Connie M. Rhee, et al.. (2022). Patient-centred approaches for the management of unpleasant symptoms in kidney disease. Nature Reviews Nephrology. 18(3). 185–198. 113 indexed citations breakdown →

10.

Lockwood, Mark B., et al.. (2021). Emerging Patient-Centered Concepts in Pain Among Adults With Chronic Kidney Disease, Maintenance Dialysis, and Kidney Transplant. Seminars in Nephrology. 41(6). 550–562. 2 indexed citations

11.

Lockwood, Mark B., Paul L. Kimmel, Laura M. Dember, et al.. (2021). Opioids for chronic pain management in patients with dialysis-dependent kidney failure. Nature Reviews Nephrology. 18(2). 113–128. 24 indexed citations

12.

Mathew, Asha, Hongjin Li, Alana Steffen, et al.. (2021). Symptom Clusters in Head and Neck Cancer: A Systematic Review and Conceptual Model. Seminars in Oncology Nursing. 37(5). 151215–151215. 24 indexed citations

13.

Diallo, Ana F., Mark B. Lockwood, Katherine A. Maki, et al.. (2020). Metabolic Profiling of Blood and Urine for Exploring the Functional Role of the Microbiota in Human Health. Biological Research For Nursing. 22(4). 449–457. 2 indexed citations

14.

Li, Hongjin, Tingting Liu, Mark B. Lockwood, et al.. (2020). Systematic Review of the Kynurenine Pathway and Psychoneurological Symptoms Among Adult Cancer Survivors. Biological Research For Nursing. 22(4). 472–484. 16 indexed citations

15.

Lockwood, Mark B. & Stefan J. Green. (2020). Clinical care is evolving: The microbiome for advanced practice nurses. Journal of the American Association of Nurse Practitioners. 32(4). 290–292. 2 indexed citations

16.

Lockwood, Mark B., James P. Lash, Heather Pauls, et al.. (2019). Physical Symptom Cluster Subgroups in Chronic Kidney Disease. Nursing Research. 69(2). 100–108. 13 indexed citations

17.

Maki, Katherine A., et al.. (2018). Considerations When Designing a Microbiome Study: Implications for Nursing Science. Biological Research For Nursing. 21(2). 125–141. 21 indexed citations

18.

Khoury, Jad A., Gregory A. Storch, Delphine Bohl, et al.. (2006). Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients. American Journal of Transplantation. 6(9). 2134–2143. 266 indexed citations

19.

Brennan, Daniel C., Irfan Agha, Daniel L. Bohl, et al.. (2005). Incidence of BK with Tacrolimus Versus Cyclosporine and Impact of Preemptive Immunosuppression Reduction. American Journal of Transplantation. 5(3). 582–594. 540 indexed citations breakdown →

20.

Hardinger, Karen L., Daniel L. Bohl, Mark A. Schnitzler, et al.. (2005). A Randomized, Prospective, Pharmacoeconomic Trial of Tacrolimus versus Cyclosporine in Combination with Thymoglobulin in Renal Transplant Recipients. Transplantation. 80(1). 41–46. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact